Synonyms: C188-9 [2] | TTI 101 | TTI101
Compound class:
Synthetic organic
Comment: TTI-101(formerly C188-9) is an orally bioavailable STAT3 transcription factor inhibitor. It blocks the tyrosine residue phosphorylation by Janus kinase (JAK) that mediates STAT3 activation, leading to downregulation of STAT3-mediated gene expression. This mechanism of action is considered as a valid approach for the treatment of inflammation, fibrosis, and a range of cancers [1,3].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[4-hydroxy-3-(2-hydroxynaphthalen-1-yl)naphthalen-1-yl]-4-methoxybenzenesulfonamide |
Synonyms ![]() |
|
C188-9 [2] | TTI 101 | TTI101 |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL3392776 |
GtoPdb PubChem SID | 473153856 |
PubChem CID | 1324494 |
Search Google for chemical match using the InChIKey | QDCJDYWGYVPBDO-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | QDCJDYWGYVPBDO |
UniChem Compound Search for chemical match using the InChIKey | QDCJDYWGYVPBDO-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | QDCJDYWGYVPBDO-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
C188-9 (links to external site)
Cat. No. HY-112288 |